A prospective, multicenter, comprehensive genomic profile signature study in patients with EGFR-mutant advanced non-small cell lung cancer at the first-line treatment failure of osimertinib
Year: 2025
Type: article
Language: en
Topic: Lung Cancer Treatments and Mutations
Authors and affiliations:
raw_author_name: Yuankai Shi
raw_affiliation_strings: Department of Medical Oncology, Beijing Key Laboratory of Key Technologies for Early Clinical Trial Evaluation of Innovative Drugs for Major Diseases, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, People's Republic of China. syuankai@cicams.ac.cn
Department of Medical Oncology, Beijing Key Laboratory of Key Technologies for Early Clinical Trial Evaluation of Innovative Drugs for Major Diseases, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, People's Republic of China
raw_author_name: Dongqing Lv
raw_affiliation_strings: Department of Breath Internal Medicine, Taizhou Hospital of Zhejiang Province, Taizhou, People's Republic of China
raw_author_name: Weineng Feng
raw_affiliation_strings: Pulmonary Oncology Department, The First People's Hospital of Foshan, Foshan, People's Republic of China
raw_author_name: Shuoyan Liu
raw_affiliation_strings: Department of Thoracic Oncology Surgery, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, People's Republic of China
raw_author_name: Puyuan Xing
raw_affiliation_strings: Department of Medical Oncology, Beijing Key Laboratory of Key Technologies for Early Clinical Trial Evaluation of Innovative Drugs for Major Diseases, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, People's Republic of China
raw_author_name: Yan Yu
raw_affiliation_strings: Department of Respiratory Medicine, Harbin Medical University Cancer Hospital, Harbin, People's Republic of China
raw_author_name: Jun Yin
raw_affiliation_strings: Pulmonary and Critical Care Medicine, The Third People's Hospital of Chengdu, Southwest Jiaotong University, Chongqing Medical University, Chengdu, People's Republic of China
raw_author_name: Xiubao Ren
raw_affiliation_strings: Department of Biotherapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China
raw_author_name: Junqiang Zhang
raw_affiliation_strings: Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital), Hefei, People's Republic of China
raw_author_name: Gaohua Han
raw_affiliation_strings: Department of Oncology, The People's Hospital of Taizhou, Taizhou Medical School, Jiangsu and Nantong University, Taizhou, People's Republic of China
raw_author_name: Yongchang Zhang
raw_affiliation_strings: Department of Lung/Gastrointestinal Oncology, Hunan Cancer Hospital, Xiangya School of Medicine, Central South University, Changsha, People's Republic of China
Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China
raw_author_name: Shundong Cang
raw_affiliation_strings: Department of Oncology, Henan Provincial People's Hospital, Zhengzhou, People's Republic of China
raw_author_name: Jun Chen
raw_affiliation_strings: Department of Oncology, The Second Hospital of Dalian Medical University, Dalian, The People's Republic of China
raw_author_name: Enguo Chen
raw_affiliation_strings: Department of Pulmonary and Critical Care Medicine, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, People's Republic of China
raw_author_name: Lingxin Meng
raw_affiliation_strings: Department of Oncology, Rizhao People's Hospital, Rizhao, People's Republic of China
raw_author_name: Yong Zhang
raw_affiliation_strings: Department of Lung/Gastrointestinal Oncology, Hunan Cancer Hospital, Xiangya School of Medicine, Central South University, Changsha, People's Republic of China
Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China